ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Renee S. Hartz
Frederick L. Grover
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hartz, R. S.
Right arrow Articles by Shroyer, A. L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartz, R. S.
Right arrow Articles by Shroyer, A. L. W.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2001;71:512-520
© 2001 The Society of Thoracic Surgeons


Original article: cardiovascular

Effects of race, with or without gender, on operative mortality after coronary artery bypass grafting: a study using The Society of Thoracic Surgeons national database

Renee S. Hartz, MDa, Anuradha V. Rao, MDa, Mary E. Plomondon, MSb, Frederick L. Grover, MDc, A. Laurie W. Shroyer, PhDb

a Department of Surgery, Tulane University Medical School, New Orleans, Louisiana, USA
b Department of Cardiac Research, Denver Veterans Affairs Medical Center, Denver, Colorado, USA
c University of Colorado, Health Sciences Center, Denver, Colorado, USA

Accepted for publication April 14, 2000.

Address reprint requests to Dr Hartz, Department of Surgery, SL22, Tulane University, 1430 Tulane Ave, New Orleans, LA 70112
e-mail: rshartzmd{at}aol.com


    Abstract
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
Background. Although gender is known to be an independent predictor of 30-day operative mortality (OM) after coronary artery bypass grafting, the purpose of this study was to determine whether race—alone or in combination with gender—affects OM.

Methods. For 1994 to 1996, The Society of Thoracic Surgeons database records for 441,542 coronary artery bypass grafting-only procedures were analyzed. Baseline annual multivariate models were built. Gender and race were added to each model. Risk-adjusted OM rates were then calculated for race, gender, and their combination. Patients were also stratified into groups of comparable predicted OM to allow for a direct comparison of risk-matched Caucasians and non-Caucasians.

Results. Of the procedures, 28.2% were on women and 8.5% on non-Caucasians. Overall, OM was 3.29%. Multivariate risk-adjusted OM varied by gender and race (p < 0.10). Risk-adjusted OM rates (with 95% confidence intervals) were 4.0% (3.9% to 4.1%) for females and 3.2% (3.2% to 3.3%) for males. Risk-adjusted OM rates were 3.9% (3.7% to 4.1%) for non-Caucasians and 3.3% (3.2% to 3.3%) for Caucasians. Among equally risk-matched Caucasians and non-Caucasians, non-Caucasians had significantly higher (p < 0.005) mortality among the lower risk subgroups (up to 10% predicted OM) but not among the higher risk subgroups.

Conclusions. Race and gender are independent predictors of adverse outcome following coronary artery bypass grafting, holding all other risk factors constant.


    Introduction
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
The Society of Thoracic Surgeons (STS) National Cardiac Database has been used previously to demonstrate that gender is an independent predictor of risk for adverse outcomes after coronary artery bypass (CABG-only) procedures in all risk subgroups except for those in the very highest risk category [1]. The literature related to risk for non-Caucasians, however, is less clear. For example, the multivariate logistic risk models built by the STS and other organizations (such as the State of New York or Duke Medical Center) did not consistently report race either as an entry variable or as a variable listed in the final risk models reported [2, 3].

Numerous studies have documented racial variations in the application of diagnostic studies (cardiac catheterization) and revascularization procedures (angioplasty and CABG) for coronary artery disease. Less certain is the impact of race on outcomes after these interventions. In the 1995 CABG-only STS risk model, the Native American race was the only race-related variable that remained in the final predictive model [4].

For the first time, the 1996 STS CABG-only multivariate model indicated that race (defined as Caucasian and non-Caucasian) was an independent predictor of operative mortality (OM) after holding all other risk factors constant [5]. Although there may be important differences in access to care based on racial subgroupings, the existing literature reveals that few studies have addressed the issue of procedural outcomes as related to race. Hence, it was our collective perception that the potential influence of race on procedural outcomes related to CABG surgery required further investigation.

The purpose of this analysis, therefore, was to determine whether race alone or in combination with gender affected the risk of 30-day operative mortality after CABG-only surgery. A concern was raised that the influence of race on OM might be explained either fully or in part by a collection of other risk factors such as severity of coronary disease or presence of comorbid disease states. For example, other studies have indicated that factors related to body size and coronary diameter have been linked to female gender as an independent risk factor for adverse events postcardiac surgery [6, 7]. Thus, the relationships of race with many other patient risk characteristics and process of care measures (such as body size and use of internal mammary artery grafts) were also explored.


    Patients and methods
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
The study population consisted of the records detailing all CABG-only procedures performed with dates of surgery from January 1, 1994 to December 31, 1996. Following data completeness and quality reviews for procedural designation and key variables required (including gender, date of surgery, procedure type, and age), the study population included 441,542 records (99.4%) out of an original 444,397 records extracted. The key study variables of gender (designated as male versus female) and race (designated as Caucasian versus non-Caucasian) were identified.

Although the anthropologic correctness of the "Caucasian" versus "non-Caucasian" categorization may be questioned, we had available to us only the racial designation provided on the STS Database forms. A more precise anthropologic categorization may be "North Western European" versus "non-North Western Europe." Given the small number of records within any race subclassification, the 1997 Expert Advisory Panel recommended that the variable for race be reclassified into two categories (Caucasian and non-Caucasian) for the 1996 STS CABG-only risk modeling process. Thus, this recommendation was used as the basis of this special analysis also.

Potential univariate interrelationships between study variables were analyzed using a Chi-square test or a Wilcoxon rank sum test. For the Chi-square tests, an adjustment (reduction of Chi-square by factor of 10) was made to account for the large size of STS population studied and a Cramer’s V was also reviewed as a measure of association to compare nominal variables (specifically, race). For reference, a Cramer’s V value less than 0.10 generally indicates a weak relationship is present (although the relationship may be statistically significant) between the variables analyzed. For model development and testing purposes, one half of all records were randomly assigned to learning and test data sets [8]. The OM rates in the learning and test data sets were reviewed to determine that no inherent bias in these six data sets existed using a Chi-square analysis. Statistical test performance metrics were evaluated appropriately [9].

Three baseline annual multivariate logistic models (for 1994, 1995, and 1996) were built according to The Society of Thoracic Surgeons standard specifications excluding the race and gender variables for comparative purposes. Univariate screening was performed to determine variables eligible for model entry.

For all records, the standard STS approved clinical data substitutions were used [5]. For race, this substitution required the records with missing race (14,854 or 3.36%) to be reclassified to Caucasian, as the clinical default category. To test this key assumption, the study’s primary multivariate analyses were rerun after dropping all records with missing race data.

As a potential measure of body morphology, both body mass index (BMI) and body surface area (BSA) variables were explored. For purposes of this study, BMI was defined according to the American Society of Clinical Nutrition’s four categories: 20 to 25 kg/m2 = normal; 26 to 30 kg/m2 = grade I obesity; 31 to 40 kg/m2 = grade II obesity; and greater than 40 kg/m2 = severe obesity [10].

The two key variables of study (gender and race) were reinserted into each baseline model as independent main effect variables. Subsequently, the interaction effect (gender-race) was assessed. The statistical significance of each of these two key variables and the interaction variable on the relative improvement in risk model performance were evaluated. The purpose of this comparative analysis was to determine in a multivariate context whether these key variables or their combination were statistically significant predictors of OM [11].

The c-index, which is a measure of each models’ predictive power, was calculated. The c-index represents the area under the receiver operating characteristic curve (which reflects the relative sensitivity and specificity of the model in predicting OM). In theory, the c-index may range from 0.5 to 1.0, where a value of 0.5 is useless for prediction purposes and a value of 1.0 represents perfect prediction. Using the method identified by Hanley and McNeil, a nested c-index comparison was performed to determine difference between the annual models’ performance, which were derived from the same cases [12].

The calibration was assessed using a Hosmer-Lemeshow (H-L) test, which determines the association between the observed OM and the estimated risks for OM from the model across deciles of patient risk [13]. In general, a model with an H-L test p value less than 0.05 indicates a lack of fit, which is poor calibration across the spectrum of patient risk. Due to inherently large sample sizes, this test statistic has been adjusted to compare with other reported logistic regression models in the literature appropriately [14]. To eliminate the possibility of a multiple comparisons problem, the c-index and H-L test results for all three annual models were calculated in aggregate on the test data set.

Risk adjusted operative mortality rates were calculated for race and gender, as well as the four combined gender/race categories. Confidence intervals were calculated for the risk-adjusted mortality rates provided for both the gender and race variables, as well as the four combined categories. In addition, the final model was used to place all patients into 7 clinically relevant subgroups of similar predicted risk (0% to 2.5%, 2.5% to 5.0%, 5.0% to 10%, 10% to 20%, 20% to 30%, 30% to 50%, and 50% to 100%) to allow direct comparisons of observed/expected operative mortality.


    Results
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
Study population
From the study population, the data for each annual period for 1994, 1995, and 1996 were analyzed separately to allow comparison to previously published STS CABG-only risk models as well as to address the inherent time-dependent trends in reduced 30-day OM over this period [15]. The number of CABG-only records analyzed was 116,700 for 1994; 150,623 for 1995; and 174,210 for 1996. The overall OM rate for all records was 3.29%.

Univariate analysis
For the study population, 8.5% of CABG procedures performed were on non-Caucasians and 28.2% were on women. Univariate analysis revealed that a statistically significant relationship existed between gender and race, confirming the perception that women undergoing CABG are more likely to be non-Caucasian than are men undergoing the procedure. For Caucasians, 27.6% of the CABG procedures were performed on women whereas for non-Caucasians, 35.3% were performed on women (p < 0.001). Table 1 illustrates the distribution of the records and deaths by both race and gender categories.


View this table:
[in this window]
[in a new window]
 
Table 1. Distribution of Records and Deaths by Race and Gender

 
In univariate analysis, Caucasians were found to be significantly different than non-Caucasians for a wide variety of risk factors (Table 2). The average age of non-Caucasians was 62.0 years in comparison to 64.8 for Caucasians (p < 0.001). For severity of cardiac diseases, the clinically relevant differences included (but were not limited to) the following: fewer non-Caucasians had a prior cardiac procedure (5.5% versus 8.8% of Caucasians; p = 0.001), more non-Caucasians exhibited New York Heart Association class IV symptoms (24.1% for non-Caucasians versus 23.4% for Caucasians; p = 0.001), and the priority of surgery was greater for non-Caucasians (surgery was elective in 63.3% of Caucasians and in 61.5% in non-Caucasians; p = 0.031). The number of diseased vessels in non-Caucasians (72.2% triple vessel disease) was similar to that in Caucasians (70.9% triple vessel disease; p = 0.093). For important comorbid conditions, the univariate differences included (but were not limited to) the following: 7.8% of non-Caucasians had renal failure versus 3.8% of Caucasians (p = 0.001) and 42.0% of non-Caucasians had diabetes versus 27.2% of Caucasians (p = 0.001). Fewer non-Caucasians (11.1%) had chronic obstructive pulmonary disease than did Caucasians (15.0%, p = 0.001).


View this table:
[in this window]
[in a new window]
 
Table 2. Distribution of Selected Risk Factors by Race Category

 
A special attempt was made to analyze the data related to the use of internal mammary artery (IMA) grafts in this population. Unfortunately, IMA data were either completely missing or was inconsistently reported across the series of IMA data fields for 24.3% of records. Thus, the IMA variable was deleted from the analysis for data completeness or quality concerns.

Multivariate analysis results
The three annual baseline models were used as the comparison for other models developed for each key variable of interest (Table 3). As BMI category did not enter any of the baseline multivariate statistical models generated (p > 0.16 for all 3-year periods), body surface area (the traditional STS measure of body morphology) was used in the baseline multivariate modeling process. The baseline model (built without race or gender) had a c-index of 0.778 with an adjusted H-L test statistic of 0.85.


View this table:
[in this window]
[in a new window]
 
Table 3. Odds Ratio Values for Variables Included in Baseline Modelsa

 
Gender and race were added as model eligible variables simultaneously. The resulting set of final study models had a c-index of 0.779 with an adjusted H-L test statistic of 0.85. For all of the three final models, race was a statistically significant predictor of OM (p < 0.10) (Table 4). Moreover, the models’ multivariate odds ratios for the race variable were 1.161, 1.204, and 1.25 for 1994, 1995, and 1996, respectively. Based on the comparative analysis for these model performance indicators, there was not a difference between the c-indices or the H-L test results for these final models as compared to the baseline models developed (p > 0.05). That is, the models with and without inclusion of the race and gender variables performed equivalently in terms of predictive power and calibration. Hence, these traditional indicators of risk model performance (c-index and H-L test) appear to be insensitive to these two very clinically important patient characteristics.


View this table:
[in this window]
[in a new window]
 
Table 4. Odds Ratio Values for Variables Included in Final Modelsa

 
For each of the three annual models, the final risk model’s variables changed with the inclusion of the race and gender fields. When the variables for race and gender were added, the use of steroids and obesity variables were dropped and the immunosuppressive therapy variable was added to the baseline 1994 model. In the 1995 model, the presence of congestive heart failure variable dropped as the gender and race variables were added. Upon the addition of gender and race variables, the presence of the hypertension variable was dropped and the cerebrovascular accident time variable was added to the 1996 baseline model. (See Table 3 and 4). Since the changes in risk model’s predictive variables (in comparing the multivariate risk models built with and without the race and gender variables) were not consistent, it is likely that a complex and dynamic process exists between the key gender and race study variables with other patient risk factors which cannot be fully explained by this comparison.

The potential for an additional influence of an enhanced interaction effect between race and gender was explored. While keeping both gender and race variables eligible for model entry, a new race-gender interaction term was added to the logistic regression analysis. Holding all other risk factors constant, this race-gender interaction term was not statistically significant predictor of OM. That is, there was no improvement in model performance when adding the designations male Caucasian, male non-Caucasian, female Caucasian, and female non-Caucasian to any of the three annual final study models (p > 0.50). Therefore, the impact of being female and being non-Caucasian upon risk of adverse outcome is related to these main race and gender effects.

Beyond the impact associated with being either female or non-Caucasian alone, there is no additional influence on risk-adjusted OM associated with being both female and non-Caucasian (based on using an interaction term in the analysis). Although the risk-adjusted OM rates were greatest for non-Caucasian females and least for Caucasian males, these categories were used for clinically relevant comparative purposes only.

Multivariate risk-adjusted OM varied be gender and race (p < 0.05). Risk-adjusted OM rates (with 95% confidence intervals) were 3.996% (3.896% to 4.099%) for females, and 3.236% (3.171% to 3.302%) for males. Risk-adjusted OM rates were 3.901% (3.704% to 4.105%) for non-Caucasians, and 3.286% (3.232% to 3.340%) for Caucasians. (See Fig 1.) Risk-adjusted OM rates varied by the four patient subgroups as follows: male Caucasians 3.236% (3.167% to 3.304%), male non-Caucasians 3.822% (3.561% to 4.098%), female Caucasians 3.994% (3.888% to 4.103%), and female non-Caucasians 4.741% (4.392% to 5.109%). (See Fig 2.)



View larger version (18K):
[in this window]
[in a new window]
 
Fig 1. Risk-adjusted mortality after coronary artery bypass grafting by race and by gender.

 


View larger version (18K):
[in this window]
[in a new window]
 
Fig 2. Operative mortality after coronary artery bypass grafting in race-gender combination categories.

 
Patients were separated into clinically relevant risk subgroups based upon commonly used parameters. Table 5 compares the subgroups for Caucasians and non-Caucasians. Non-Caucasians were found to have significantly higher mortality rates among the low risk subgroups (up to 10% of predicted operative mortality). There were no significant differences found among the higher risk subgroups. Table 6 compares the clinical subgroups by gender. Women were found to have significantly higher mortality among the lowest risk subgroups (up to 5% of predicted operative mortality), but not among the higher risk subgroups.


View this table:
[in this window]
[in a new window]
 
Table 5. Comparison of Operative Mortality for Predicted Risk (by Clinical Grouping)

 

View this table:
[in this window]
[in a new window]
 
Table 6. Comparison of Operative Mortality for Predicted Risk (by Clinical Grouping)

 
According to the STS Expert Panel’s recommendation, records with missing race were recoded as "Caucasian." To test this assumption, the study’s primary multivariate analyses were rerun after removing all the records with missing race data. No differences in the statistical significance of the race, the gender, and the race-gender interaction variables were found. Thus, this study’s conclusions have been verified to be robust for this assumption.


    Comment
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
Risk stratification of patients referred for cardiac surgical procedures is a fundamental obligation of the surgeon as part of the clinical decision-making process. Moreover, a description of the risk-benefit ratio of the procedure is an integral component of the patient’s informed consent. The use of risk models to evaluate "at risk" patient populations—such as minorities or women—is therefore of particular importance.

Many studies have reported that radical variations exist in the application of diagnostic and therapeutic procedures for coronary artery disease including cardiac catheterization acute infarct intervention with lytic therapy, angioplasty, and bypass surgery [1618]. The literature correlating race with outcomes after such interventions is less clear. Oberman and Cutter demonstrated that whites are more likely to have CABG than blacks, but that the two racial groups had similar survival rates after bypass surgery [19]. Maynard and colleagues showed that the black race is correlated with poor survival with medical therapy of coronary artery disease, but not with surgical therapy [20]. Data from the National Hospital Discharge Summary shows that black men with acute myocardial infarction have angioplasty and CABG less often than white men with myocardial infarction. Furthermore, even though this diagnosis was more common in black than in white women, black women had significantly lower rates of cardiac catheterization and CABG [18]. For over 10,000 patients reported in the National Hospital Discharge Summary in 1997, CABG and coronary angioplasty were performed most often in white men, next in black men, then in white women, and least often in black women even when controlling for other risk factors. Similarly, in a study published at Duke University in 1997, blacks with coronary artery disease were significantly less likely than whites to undergo coronary revascularization, especially bypass surgery. The differences in treatment were most pronounced among those patients predicted to benefit most from revascularization, suggesting that coronary revascularization was underused in blacks [21].

Medicare data also reveal striking differences in the application of CABG procedures, the overall national rate being 25.6 per 100,000 population, but 27.1 for whites and 7.6 for blacks. Interestingly, gender differences in the application of CABG appear to be less striking. In whites, the rate is 40.4 for men, 16.2 for women. In blacks, the rate is 9.3 for men and 6.4 for women. The Medicare study also concluded that there are geographic differences in the rates of CABG applications [22]. Information obtained from the Veterans Administration demonstrates that regionalization of services (cardiac catheterization, angioplasty, and CABG) results in an increased likelihood of having a procedure performed, especially in elderly and African American patients [23]. Although there is less information related to other racial subgroups, non-Caucasian women in California (Asian and Latino) received CABG less often than men, and minority patients less often than whites [24]. The reason for these racial differences are unclear but may be associated with a complex combination of related to environment, biology, and genetic predisposition.

We therefore sought to determine whether non-Caucasian patients undergoing CABG-only (based on the racial characteristic variable for 8.5% of procedures entered in the STS Database) have different outcomes than do Caucasian patients. In the process of our analysis, we discovered a statistically significant, although weak association between race and gender (women having CABG are more likely to be non-Caucasian than are men). This finding prompted us to further analyze the patients based on race-gender subgroups.

A preliminary univariate analysis of this large population of patients demonstrated striking differences in the risk profiles of the four separate subgroups (male Caucasian, male non-Caucasian, female Caucasian, and female non-Caucasian). The major study risk factors (race and gender) were analyzed separately and in combination, holding all other patient risk factors constant. Advanced age, severity of coronary artery disease (left main and triple vessel), nonelective operation, reoperation, renal failure, and chronic obstructive lung disease are each known to independently affect OM and CABG in an adverse fashion. All of these attributes were controlled in our multivariate analysis of race and gender.

Less certain are the effects of body size and of the use of the left internal mammary artery as a bypass graft. The tiered classification system established for BMI did not enter any of the baseline multivariate models. This BMI classification, although viewed as clinically relevant, did not appear to have an independent impact on risk of operative death holding all other factors constant. To account for body morphology, therefore, body surface area was used in the standardized STS risk modeling approach.

A problem with data completeness and quality was also encountered when we attempted to analyze the effects of left internal mammary artery grafting on outcome. In 24.3% of the CABG records, the IMA fields were missing, or completed with inconsistent data. For IMA use, we could not determine a satisfactory method of dealing with missing data. Due to an observed bias related to the member sites either completing or not completing these sections of the data form, the IMA variable was deleted from the remainder of the analysis.

We were able to conclusively demonstrate that non-Caucasian race is a multivariate predictor of operative mortality after CABG-only, holding all other patient risk factors constant. Female gender had a similar negative impact on operative outcome. Although there were significantly more non-Caucasian patients in the female group than in the male group (confirming an univariate relationship between race and gender), we could not demonstrate that the combination of race and gender interaction multivariately produced any additional impact beyond these two main attributes.

Across all 3 years, the addition of the race and gender variables to the baseline multivariate risk models did not result in uniform changes to the predictor variable test. Thus, the relationship between race and gender variables with other predictor variables appears to be complex. Further research may be needed to comprehensively identify the diverse set of factors influencing the differential 30-day operative death rates for non-Caucasian and female subgroups.

Risk stratification by commonly accepted clinical subgroups allowed for direct comparison by race and by gender. Both female gender and non-Caucasian race have significantly higher mortality rates among the lower- risk clinical subgroups. As predicted risk increases, the observed differences in 30-day operative mortality rates do not appear to be influenced by race or gender.

As with all other national databases, The Society of Thoracic Surgeons National Adult Cardiac Database faces inherent data completeness and quality challenges. The data collection form is complex and the data entry may be performed retrospectively. Second, the assigned risk estimate cannot easily be calculated remotely at the patient bedside to facilitate the clinical decision-making process. Finally, this database is composed largely of male Caucasian patients. Still, our analysis, which mandated exclusion of those records not containing a minimum set of hard data points (related to age, date of surgery, gender, and procedure type) yielded information concerning the effects of face on CABG outcome, and supplements the existing literature on gender.

Almost a decade ago, when the high operative mortality rates for women undergoing CABG first came under scrutiny, a review of the literature led Dr Janet Bickell to conclude that women were less likely than men to be referred for CABG if their risk was low, but equally likely to be referred if their risk for operative mortality was high. She postulated that the "referral bias" being observed in women was actually a reflection of more appropriate treatment for women than for men [25]. The present analysis indicates that the same principles may apply to non-Caucasian patients. However, our conclusions that non-Caucasian and female patients have worse risk-adjusted outcomes after CABG are not to be interpreted that these groups should have bypass surgery less often. Rather, they should challenge us to further investigate the basis of these discrepancies in the future, as well as to evaluate other outcomes of care (such as morbidity, length of stay, and cost) for these special "at risk" populations [26].

There are several limitations of this study. First, the non-Caucasian group was not further stratified. Since coronary artery disease is the leading cause of death in African-Americans, an analysis of this particular subgroup should be undertaken. Second, there was no designation for coding "diffuse coronary artery disease," a condition that may be more prevalent in one racial subgroup than in another. Even more importantly, we did not have access to those parameters that would have allowed an analysis of the socioeconomic status of each patient, a factor that may be a powerful determinant of outcome [27]. Additionally, the inability to evaluate the impact of use of the left internal mammary artery as a bypass graft conduit upon operative mortality is a major limitation of our analysis. Clearly, there may be complex interactions between other patient risk characteristics and processes of care with CABG outcomes that we were unable to evaluate using the current data available. The current efforts of the STS Database Committee (both to simplify the data collection form and prioritize the data capture efforts) should have a major impact on improving data quality and completeness. Thus, more complete and comprehensive data will be available to facilitate future studies in this area.


    References
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 

  1. Edwards F.H., Carey J.S., Grover F.L., Bero J.W., Hartz R.H. Impact of gender on coronary bypass operative mortality. Ann Thorac Surg 1998;66:125-131.[Abstract/Free Full Text]
  2. Edwards F.H., Grover F.L., Shroyer A.L., Schwartz M., Bero J. The Society of Thoracic Surgery national cardiac surgery database: current risk assessment. Ann Thorac Surg 1997;63:903-908.[Abstract/Free Full Text]
  3. Hannan E.L., Kilburn H., O’Donnell J.F., Lukacik G., Shields E. Adult open heart surgery in New York State: an analysis of risk factors and hospital mortality rates. JAMA 1990;264:2678-2774.
  4. Shroyer A.L., Grover F.L., Edwards F.H. 1995 coronary artery bypass risk model: The Society of Thoracic Surgeons adult cardiac national database. Ann Thorac Surg 1998;65:879-884.[Abstract/Free Full Text]
  5. Shroyer A.L., Plomondon M.E., Grover F.L., Edwards F.H. 1996 coronary artery bypass risk model: The Society of Thoracic Surgeons adult cardiac national database. Ann Thorac Surg 1999;67:1205-1208.[Abstract/Free Full Text]
  6. Christakis G., Weisel R., Ruth K., et al. Is body size the cause for poor outcomes of coronary artery bypass operations in women?. J Thorac Cardiovasc Surg 1995;110:1344-1358.[Abstract/Free Full Text]
  7. Loop F.D., Golding L.R., Macmillan J.P., Cosgrove D.M., Lytle B.W., Sheldon W.C. Coronary artery surgery in women compared with men: analyses of risks and long-term results. J Am Coll Cardiol 1983;1:383-390.[Abstract]
  8. Carmines E.G., Zeller R.A. Reliability and validity assessment. Newbury Park, CA: Sage Publications, 1979.
  9. Ash A., Schwartz M. Evaluating the performance of risk-adjustment methods: dichotomous variables. In: Lezzoni L., ed. Risk adjustment for measuring health care outcomes. Ann Arbor, MI: Health Administration Press, 1994:313-346.
  10. Bray G.A. Pathophysiology of obesity. Am J Clin Nutr 1992;55(Suppl 2):488S.[Abstract/Free Full Text]
  11. Shroyer A.L., Marshall G., Warner B., et al. No continuous relationship between CABG volume and operative mortality. Ann Thorac Surg 1996;61:17-20.[Abstract/Free Full Text]
  12. Hanley A.J., McNeil B.J. A method of comparing the areas under the receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.[Abstract/Free Full Text]
  13. Hosmer D.W., Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, 1989.
  14. Shroyer A.L.W., Grunwald G.K., Edwards F.H., Grover F.L. CABG risk model: a reply. Ann Thorac Surg 1998;66:1471.[Free Full Text]
  15. Edwards F.H., Clark R., Schwartz M. Coronary artery bypass grafting: The Society of Thoracic Surgeons national database experience. Ann Thorac Surg 1994;57:12-19.[Abstract]
  16. Scott N.A., Kelsey S.F., Detre K., Cowley M., King S.B., 3rd Percutaneous transluminal coronary angioplasty in African-American patients. National Heart, Lung, and Blood Institute 1985–1986 percutaneous transluminal coronary angioplasty registry. Am J Cardiol 1994;73:1141-1146.[Medline]
  17. Maynard C., Fisher L.D., Passamani E.R., Pullum T. Blacks in the coronary artery surgery study (CASS): race and clinical decision making. Am J Public Health 1986;76:1446-1448.[Abstract/Free Full Text]
  18. Giles W.H., Anda R.F., Casper M.L., Escobedo L.G., Taylor H.A. Race and sex differences in rates of invasive cardiac procedures in US hospitals. Data from the national hospital discharge survey. Arch Intern Med 1995;155:318-324.[Abstract/Free Full Text]
  19. Oberman A., Cutter G. Issues in the natural history and treatment of coronary heart disease in black populations: surgical treatment. Am Heart J 1984;108:688-694.[Medline]
  20. Maynard C., Fisher L.D., Passamani E.R. Survival of black persons compared with white persons in the coronary artery surgery study (CASS). Am J Cardiol 1987;60:513-518.[Medline]
  21. Peterson E.D., Shaw L.K., DeLong E.R., Priyor D.B., Califf R.M., Mark D.B. Racial variation in the use of coronary revascularization procedures. Are the differences real? Do they matter?. New Engl J Med 1997;336:480-486.[Abstract/Free Full Text]
  22. Goldberg K.C., Hartz A.J., Jacobsen S.J., et al. Racial and community factors influencing coronary artery bypass graft surgery rates for all 1986 Medicare patients. JAMA 1992;267:1473-1477.[Abstract/Free Full Text]
  23. Mirvis D.M., Graney M.J. Impact of race and ages of the effects of regionalization of cardiac procedures in the Department of Veterans Affairs health care system. Am J Cardiol 1998;81:982-987.[Medline]
  24. Giacomini M. Gender and ethnic differences in hospital-based programs. California. Arch Intern Med 1996;156:1217-1224.[Abstract/Free Full Text]
  25. Bickell N.A., Pieper K.S., Lee K.L., et al. Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment?. Ann Intern Med 1992;116:791-797.
  26. Hartz RS, Charney P. Coronary artery bypass grafting. Is it worth the risk? In: Charney P, ed. Coronary artery disease in women. American College of Physicians Women’s Health Series Philadelphia: 1999:438–62.
  27. Higgins R.S., Paone G., Borzak S., Jacobsen G., Peterson E., Silverman N.A. Effect of payor status on outcome of coronary artery bypass surgery in blacks. Circulation 1998(Suppl I):II1146.



This article has been cited by other articles:


Home page
CirculationHome page
W. A. Cooper, V. H. Thourani, R. A. Guyton, P. Kilgo, O. M. Lattouf, E. P. Chen, C. D. Morris, J. D. Vega, T. A. Vassiliades Jr, and J. D. Puskas
Racial Disparity Persists After On-Pump and Off-Pump Coronary Artery Bypass Grafting
Circulation, September 15, 2009; 120(11_suppl_1): S59 - S64.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
R. Matyal
Newly Appreciated Pathophysiology of Ischemic Heart Disease in Women Mandates Changes in Perioperative Management: A Core Review
Anesth. Analg., July 1, 2008; 107(1): 37 - 50.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. H. Han, J. H. Bae, D. R. Holmes Jr, R. J. Lennon, E. Eeckhout, G. W. Barsness, C. S. Rihal, and A. Lerman
Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis
Eur. Heart J., June 1, 2008; 29(11): 1359 - 1369.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. N. Bairey Merz, L. J. Shaw, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, C. J. Pepine, S. Mankad, B. L. Sharaf, et al.
Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender Differences in Presentation, Diagnosis, and Outcome With Regard to Gender-Based Pathophysiology of Atherosclerosis and Macrovascular and Microvascular Coronary Disease
J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S21 - S29.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. Trivedi, T. D. Sequist, and J. Z. Ayanian
Impact of Hospital Volume on Racial Disparities in Cardiovascular Procedure Mortality
J. Am. Coll. Cardiol., January 17, 2006; 47(2): 417 - 424.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Zacharias, T. A. Schwann, C. J. Riordan, S. J. Durham, A. Shah, and R. H. Habib
Operative and Late Coronary Artery Bypass Grafting Outcomes in Matched African-American Versus Caucasian Patients: Evidence of a Late Survival-Medicaid Association
J. Am. Coll. Cardiol., October 18, 2005; 46(8): 1526 - 1535.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. M. Shahian, E. H. Blackstone, F. H. Edwards, F. L. Grover, G. L. Grunkemeier, D. C. Naftel, S. A.M. Nashef, W. C. Nugent, and E. D. Peterson
Cardiac Surgery Risk Models: A Position Article
Ann. Thorac. Surg., November 1, 2004; 78(5): 1868 - 1877.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. M. Rothenberg, T. Pearson, J. Zwanziger, and D. Mukamel
Explaining disparities in access to high-quality cardiac surgeons
Ann. Thorac. Surg., July 1, 2004; 78(1): 18 - 24.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
B. Perek, M. Jemielity, and W. Dyszkiewicz
Why Are the Results of Coronary Artery Bypass Grafting in Women Worse?
Asian Cardiovasc Thorac Ann, December 1, 2003; 11(4): 293 - 298.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. R. Bridges
Cardiac surgery in African Americans
Ann. Thorac. Surg., October 1, 2003; 76(4): S1356 - 1362.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. L. W. Shroyer, L. P. Coombs, E. D. Peterson, M. C. Eiken, E. R. DeLong, A. Chen, T. B. Ferguson Jr, F. L. Grover, and F. H. Edwards
The society of thoracic surgeons: 30-day operative mortality and morbidity risk models
Ann. Thorac. Surg., June 1, 2003; 75(6): 1856 - 1865.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. A. Nussmeier, M. R. Marino, and W. K. Vaughn
Hormone replacement therapy is associated with improved survival in women undergoing coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1225 - 1229.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
J. S. Rumsfeld, M. E. Plomondon, E. D. Peterson, M. G. Shlipak, C. Maynard, G. K. Grunwald, F. L. Grover, and A. L. W. Shroyer
The impact of ethnicity on outcomes following coronary artery bypass graft surgery in the Veterans Health Administration
J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1786 - 1793.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R.-K. R. Chang, A. Y. Chen, and T. S. Klitzner
Female Sex as a Risk Factor for In-Hospital Mortality Among Children Undergoing Cardiac Surgery
Circulation, September 17, 2002; 106(12): 1514 - 1522.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
C. Romualdi, D. Balding, I. S. Nasidze, G. Risch, M. Robichaux, S. T. Sherry, M. Stoneking, M. A. Batzer, and G. Barbujani
Patterns of Human Diversity, within and among Continents, Inferred from Biallelic DNA Polymorphisms
Genome Res., April 1, 2002; 12(4): 602 - 612.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Renee S. Hartz
Frederick L. Grover
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hartz, R. S.
Right arrow Articles by Shroyer, A. L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartz, R. S.
Right arrow Articles by Shroyer, A. L. W.
Related Collections
Right arrow Coronary disease


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS